ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,775
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Gemtuzumab ozogamicin (Mylotarg®; Pfizer/Wyeth) ADC Review
Author(s):
Publication date:
Read this article at
ScienceOpen
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Annual Reviews: Coronavirus Research
Data availability:
Comments
Comment on this article
Sign in to comment
Similar content
2,775
A low-dose triphasic oral contraceptive**Presented in part at the Thirty-Second Annual Meeting of the Pacific Coast Fertility Society, September 19 to 23, 1984, Rancho Mirage, California.††Funding and study drug were provided by Wyeth Laboratories, Inc., Philadelphia, Pennsylvania.
Authors:
Robert C. Canavan
,
Anne Butler
,
Theodore B. Woutersz
…
NIAID teams with Wyeth on HIV/AIDS vaccine. Available: http://www.nih.gov/news/pr/may2002/niaid-17.htm
Authors:
Gemtuzumab ozogamicin for the treatment of acute promyelocytic leukemia: mechanisms of action and resistance, safety and efficacy
Authors:
M Breccia
,
F Lo-Coco
,
F Lo Coco
See all similar
Cited by
1
Acquired Resistance to Antibody-Drug Conjugates
Authors:
Denis Collins
,
Birgit Bossenmaier
,
Gwendlyn Kollmorgen
…
See all cited by